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Introduction
Evaluation of lymph nodes is an integral part in the management 
of women with gynecologic cancers. Pelvic and aortic 
lyphadenectomy is widely used as a staging and/or prognostic 
procedure in gynecologic malignancies [1,2]. Nevertheless, 
although the removal of lymph nodes containing metastases 
may have some therapeutic effect, it is still considered 
controversial [2]. The growing use of laparoscopic surgery in the 
management of gynecologic malignancies has become evident 
[3] and is being gradually accepted by the medical community. 
Since several authors developed surgical techniques to perform 
pelvic and aortic lymphadenectomy using a laparoscopic 
approach [4,5], the latter has been compared with laparotomic 
lymphadenectomy. Despite the obvious advantages offered 
by the laparoscopic approach, such a lower morbidity, pelvic 
and paraaortic lymphadenectomy must fulfill the oncologic 
standards of open surgery for optimal results. The purpose of 
this study was to describe our experience with pelvic and aortic 
laparoscopic lymphadenectomy and evaluate the safety and 
feasibility of laparoscopic pelvic and aortic lymphadenectomy 
for gynecologic malignancies. 
Material and Methods
Laparoscopic pelvic and/or aortic lymphadenectomy was 
performed in 372 women for cervical (n=99), ovarian (n=63) 
and endometrial malignancies (n=210) at the Department of 
Gynecology Oncology of the University General Hospital of 
Castellon and the Department of Obstetrics and Gynecology of 
Hospital de Sant Pau y Santa Tecla. Tarrragona between January 
2004 and December 2015. All these procedures were performed 
in a standarized fashion by two oncology surgeons (J.L.H., A.Ll. 
and J.S.). 
We conducted a retrospective review of all patients, analyzing 
the demographic data on patients (age, body mass index 
(BMI)), operating times for pelvic and aortic laparoscopic 
lymphadenectomy, histopathological results, number of 
harvested lymph nodes, and lymphadenectomy-related 
complications. 
Duration of surgery was defined from the time of incision of the 
peritoneum until complete removal of all lymph nodes from the 
corresponding area [6].
Adverse events were classified into intraoperative and 
postoperative. Intraoperative injuries were categorized 
into vascular, urinary, intestinal, neurological, and other. 
Postoperative complications included events resulting up to 
6 months after surgery. Complication severity was evaluated 
following the Clavien-Dindo´s Classification of Surgical 
Complications [7]. 
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All of the patients were provided with an informed consent for 
potential complications and the possibility of conversion to 
laparotomy. 
The study approval was not required by the General University 
Hospital of Castellon Ethics Committee because this study did 
not entail experimental procedures. Data was analyzed with the 
Statistical Package for the Social Science software, version 22.0. 
Operative techniques
The patient was put into lithotomy position. A left-sided 
retroperitoneal laparoscopic approach was used, when it was 
required, for all endometrial and cervical cancer cases in this 
study. Our surgical technique is based on Querleu and Dargent's 
technique as reported by other authors [8-10]. The surgeon 
was on the left side of the patient. Four trocars were placed: 
one 12 mm supraumbilical Hasson trocar, one 10 mm Hasson 
in the axillary line 2-3 cm above the iliac crest and two 5 mm 
trocars in the median axillary line midway between the iliac 
crest and last rib [11]. Our dissection encompasses the nodal 
bearing tissue from the mid-portion of the common iliac arteries 
and extends to the left renal vein. We remove the entire left 
para-aortic lymph nodes. All lymph nodes were removed via an 
endoscopic bag through the 10 mm trocar to prevent port site 
metastases. In case of advanced cervical cancer, in which only 
aortic lymphadenectomy was required, the retroperitoneum was 
opened into the abdominal cavity after each case in order to 
prevent lymphocyst formation.
For ovarian tumors or when the peritoneum of the left paracolic 
gutter was opened, a transperitoneal lymphadenectomy is 
performed. We remove para-aortic nodes, and lymphatic nodes 
around the cava. In this case, the surgeon is positioned between 
the legs of the patient. We use 6 trocars: one 10 mm Hasson 
supraumbilical, one 10 mm trocar supraubic, two 5 mm trocar in 
both iliac fossaes, and two 10 mm trocar in the same line as the 
5 mm trocars, parallel to the supra umbilical trocar. 
When pelvic and aortic lymphadenectomy procedures are 
combined, we usually perform the extraperitoneal aortic 
lymphadenectomy first, to maintain the integrity of the peritoneum, 
followed by the transperitoneal pelvic lymphadenectomy.
In laparoscopic pelvic lymphadenectomy, 4 trocars are placed 
and the surgeon remaines on the left side of the patient. One 
12 mm Hasson trocar suprabumbilical, one 10 mm trocar 
suprapubic region and two 5 mm trocars are placed in both 
iliac fossae. We initiate our approach by opening the pelvic 
peritoneum between the round ligament and the gonadal vessels, 
extending the incision cephalad toward the ipsilateral paracolic 
gutter. We identified anatomic structures: the psoas muscle, the 
genitofemoral nerve, the external and iliac vessels, the obturator 
nerve, the umbilical artery and the ureter. We then remove in 
monobloc the superficial obturator, external iliac and common 
iliac lymph nodes. The extraction is made in endoscopic bags 
through the suprapubic trocar and through the vagina in cases 
requiring a hysterectomy. 
We perform lymph node dissection using bipolar energy and, 
in case of aortic lymphadenectomy, we use a forceps for vessel 
sealing (LigaSureTM, 5 mm, blunt tip, Medtronic).
Additional surgical procedures were performed, as needed, 
after the laparoscopic lymphadenectomy, such as: laparoscopic 
hysterectomy or radical hysterectomy, bilateral salpingo-
oophorectomy, omentectomy and appendectomy. 
All fascial incisions equal to or greater than 1 cm were closed 
with delayed absorbable suture.
Results
Two hundred and forty combined pelvic and paraaortic 
lymphadenectomies were performed, while 108 and 24 
patients underwent pelvic and aortic lymphadenectomy 
respectively. Transperitoneal approach was used in 100% of 
the pelvic lymphadenectomy procedures and in 17% of all 
aortic lymphadenectomy. An extraperitoneal approach was 
performed in 83% of all aortic lymphadenectomy procedures. 
In 24 patients an extraperitoneal paraaortic lymphadenectomy 
was performed exclusively to complete staging of cervical or 
endometrial cancer.
The median age and body mass index of the patients were 60 
years (range 23-97 years) and 29.75 kg/m2 (range 18-51 kg/m2). 
Table 1 shows the epidemiological characteristics of the studied 
population. Indications for laparoscopic lymphadenectomy are 
shown in Table 2. The mean operative times were 40 min (20-
89) for a complete pelvic lymphadenectomy, 62 min (21-151) 
for transperitoneal aortic lymphadenectomy and 45 min (35-65) 
for a retroperitoneal approach. Conversion to laparotomy was 
needed in 1.6% of patients (6 cases). 
In patients with pelvic lymphadenectomy, an average of 13.6 
(range 1-34) lymph nodes were harvested. The median of aortic 
nodal count was 2 (range 2-31) in the transperitoneal approach 
and 9 (range 5-20) in the retroperitoneal approach. 
Positive para-aortic lymph nodes were present in 7 patients 
(1.88%), while 16 patients (4.3%) presented positive pelvic 
nodes. Twenty-three (6.1%) complications were encountered 
in 372 patients undergoing laparoscopic lymphadenectomy. 
Nine (2.4%) major complications occurred intraoperatively 
and fourteen (3.7%) postoperatively. The most frequent 
intraoperatory complication was vascular injury (1.3%). The 
vena cava was damaged in two patients, the left renal vein 
in one patient and the external iliac vein were injured in two 
patients. Laparotomy was performed in one patient to control 
bleeding in an external iliac vein lesion. The injury was 
corrected by a vascular surgeon using a vascular prosthesis. 
In the other cases, the surgeon repaired these lacerations with 
laparoscopic intracorporeal suturing using 4-0 polypropylene 
and postoperative recovery was uneventful. Two cases of injury 
Age (years), mean (range) 60 (23-97)
BMI (Kg/m2), mean (range) 29,75(18-51)
Previous abdominal surgery, n (%) 119 (31.9) 
Comorbidities, n (%)
History of diabetes 37 (9.9)
History of hypertension 114 (30.6)
History of respiratory disease 26 (7)
History of cardiovascular disease 29 (7.8)
Tumor origin, n(%)
Cervix 99 (26.6)
Ovary 63 (16.9)
Endometrium 210 (56.45) 
BMI: Body Mass Index
Table 1.Summary of patient characteristics.
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to the ureter were reported; one during transperitoneal aortic 
lymphadenectomy and the other during pelvic dissection. All 
of them were repared by placing double-J catheters. One case 
of obturator nerve transaction occurred requiring laparoscopic 
repair. Three cases of bowel perforation occurred. In one patient 
large intestine was injured due to excessive traction applied 
by the assisting surgeon during pelvic lymphadenectomy. In 
another two patients the complications appeared during the 
postoperative time. 
The other postoperative complications included four cases of 
paralytic ileum, two cases of incisional hernia, two symptomatic 
lymphoceles and four lymphedemas. All these patients were 
managed with conservative treatment except for the incisional 
hernias, which required surgical repair. We observed no 
postoperative hemorrhage caused by the lymphadenectomy. No 
thromboembolic events were reported (Table 3).
With regards to our operative findings, no patient required 
reoperation nor were there any readmitted to the hospital after 
discharge.
Discussion
Minimally invasive surgery has become an option in the surgical 
management of early gynecologic malig-nancies. Several studies 
have demonstrated that laparoscopic lymphadenectomy is a 
safe and effective technique. There are many widely recognized 
advantages of a minimally invasive approach for gynecolo-gic 
malignancies compared to open surgery, which include less 
pain, smaller incisions, quicker recovery, shorter hospital stays, 
decreased blood loss, equivalent nodal counts, and in some 
reports, similar survival; however, there is an increased duration 
of surgery compared to the laparotomy approach [2,12-19].
In the present study, pelvic laparoscopic lymphadenectomy 
always used four trocars including a 12 mm Hasson 
supraumbilical trocar, a 10 mm suprapubic trocar, and two 5 mm 
trocars in both iliac fossae. This approach has been described 
by other authors but in our case the surgeon was positioned to 
the left side of the patient and not on the right as described by 
Dottino et al. [18]. Unlike other publications where the surgeon 
performs the right pelvic lymphadenectomy from the left side 
and the left from the right side [2], we performed both pelvic 
sides with the surgeon positioned on the left side. To perform 
the aortic retroperitoneal lymphadenectomy, we followed the 
technique described by Querleu, positioning ourselves on the 
left side of the patient [2,4]; however, some authors performed 
it positioning themselves on the right side of the patient [18,20]. 
For the transperitoneal aortic approach, we used the technique 
described earlier in this paper, also used by other authors [21] 
but with a slight modification of trocar placement.
Laparoscopic lymphadenectomy can be done transperitoneally 
or retroperitoneally. The transperitoneal approach is 
preferred in most studies [2,4,8,18,20,22,23]. Transperitoneal 
lymphadenectomy allows inspection of the abdominal cavity 
including biopsies and intraperitoneal lavage for cytology. The 
retroperitoneal approach is associated with better exposure 
since the bowel is displaced by the elevated peritoneum [8,24]. 
In our series, we used the transperitoneal approach exclusively 
for the pelvic lymphadenectomy. For aortic lymphadenectomy 
in early ovarian cancer, we used transperitoneal approach, 
which allows a better excision of lymph nodes around the 
aorta and cava vein. In case of advanced cervical cancer or 
endometrial cancer we performed staging retroperitoneal aortic 
lymphadenectomy approach prior to radiotherapy because 
appears to be superior to the traditional open approach [25]. A 
body mass index of more than 30 or 35 is seen as the upper limit 
for laparoscopic paraaortic lymphadenectomy for some authors 
[26-29]. Although obesity is considered a limiting factor for 
laparoscopic lymphadenectomy [23,30], our group believes that 
laparoscopy, in hands of a skilled surgeon, is a good technique 
for gaining access to the retroperitoneal space, especially in 
patients with endometrial cancer. In our study we performed 
aortic retroperitoneal lymphadenectomy in 20 patients with 
cervical cancer with a median BMI of 24.2 and in 4 patients 
with endometrial cancer with a BMI of 30.9. 
Some authors use the monopolar energy [20] or ultrasound 
[21,31] for resection of lymph nodes. Our team uses bipolar 
energy and vessel sealer because we think it has less risk of 
vascular lesions, ureter or bowel. 
Cervix No. of patients Endometrium No. of patients Ovary No. of patients
Squamous cell carcinoma 81 Endometrioid adenocarcinoma 189
Endometrioid 
adenocarcinoma 11
Adenocarcinoma 12 Serous/Clear cell adenocarcinoma 6
Mucinous 
adenocarcinoma 11
Large cell neuroendocrine 
carcinoma 2
Endometrial stromal 
sarcoma 4
Serous 
adenocarcinoma 32
Clear cell carcinoma 1 Malignant mixed müllerian tumor 4 Other 9
Other 6 Other 7
TOTAL 99 210 63 372
Table 2. Indication for laparoscopic lymphadenectomy.
Intraoperative complications 9(2.4%)
Vascular injury 5
Ureteral injury 2
Obturator nerve transection 1
Bowel lesion 1
Postoperative complications 14(3.7%)
Bowel lesion 2
Paralytic ileum 4
Incisional hernia 2
Symptomatic lymphocele/lymphedema 6
Table 3. Intraoperative and postoperative complications. 
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On average, 13.6 pelvic lymph nodes (range 1-34) and 2 (range 
2-31) aortic lymph nodes in transperational approach and 9 (range 
5-20) in retroperitoneal approach were removed in our study. 
These results are similar to those reported in other series [32].
The rate of major complications varies between 1% and 11.9% 
[2,18,20,23,26,28,33]. Our data analysis reveals a complication 
rate of 6.1%. Our most common complication was a major 
vessel injury. In the present study, 5 (1.3%) cases of major vessel 
injuries occurred during the lymphadenectomy, according to 
previous studies [31,34]. All vascular injuries were successfully 
managed using an intracorporeal suture technique, except one 
which was corrected by a vascular surgeon using a vascular 
prosthesis. Other less frequent intraoperative complications 
were visceral lesions including bowel perforation, ureteral 
injury, and obturator nerve transection, which have also been 
reported in other studies [2,22,31]. The rate of conversion to 
laparotomy was 1.6%. 
Postoperative complications were paralytic ileum (4), incisional 
trocar hernias (2), lymphocyst (2) and lymphedema (4). Our rate 
of postoperative complications is comparable to other studies 
[35,36].
Major intraoperative complications occurred mainly in the 
first 6 years, whereas major postoperative complications were 
observed throughout the study. 
The main limitation of our study is the fact that our postoperative 
data is incomplete since we could not perform a thorough 
and systematic follow up for all our patients, which is why 
our results may underestimate the true incidence rate of this 
complication in our series. Another limitation of the study is that 
the majority of our patients laparoscopic lymphadenectomy was 
combined with additional operations of different extent. In this 
heterogeneous cohort of patients, postoperative complications 
and morbidity are difficult to correlate with the laparoscopic 
part of the operation.
Conclusion
Laparoscopic lymphadenectomy can be considered a technically 
feasible and safe procedure and could be considered the golden 
standard procedure for staging gynecologic malignancies. Our 
results could reinforce the published data regarding laparoscopic 
lymphadenectomy. 
We believe that laparoscopic lymphadenectomy will eventually 
be widely performed by gynecologic oncologists and may be 
implemented in any gynecologic oncologic center. 
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